DEAD-box helicases play essential roles in RNA metabolism across species, but emerging data suggest that they have additional functions in immunity. Through RNAi screening, we identify an evolutionarily conserved and interferon-independent role for the DEAD-box helicase DDX17 in restricting Rift Valley fever virus (RVFV), a mosquito-transmitted virus in the bunyavirus family that causes severe morbidity and mortality in humans and livestock. Loss of Drosophila DDX17 (Rm62) in cells and flies enhanced RVFV infection. Similarly, depletion of DDX17 but not the related helicase DDX5 increased RVFV replication in human cells. Using crosslinking immunoprecipitation high-throughput sequencing (CLIP-seq), we show that DDX17 binds the stem loops of host pri-miRNA to facilitate their processing and also an essential stem loop in bunyaviral RNA to restrict infection. Thus, DDX17 has dual roles in the recognition of stem loops: in the nucleus for endogenous microRNA (miRNA) biogenesis and in the cytoplasm for surveillance against structured non-self-elements.
INTRODUCTION
RNA helicases control nearly every facet of RNA metabolism, including transcription, splicing, miRNA biogenesis, translation, and decay (Linder and Jankowsky, 2011) . Comprising the largest family of helicases, the DEAD-box proteins are found in all three kingdoms of life and share 12 conserved motifs, including the DEAD motif characterized by the amino acids Asp-Glu-AlaAsp. Although DEAD-box proteins are most appreciated for their roles in RNA metabolism, some have important functions in antiviral defense. For example, mammalian retinoic acid-inducible gene 1 (RIG-I/DDX58) and myeloma differentiation-associated factor 5 (MDA-5), collectively termed RIG-I-like receptors (RLRs), recognize non-self-elements in viral RNAs such as double-stranded RNA (dsRNA) and 5 0 -triphosphorylated RNA, leading to the transcriptional induction of Type I interferon (IFN-I) and proinflammatory cytokines (Loo and Gale, 2011) . However, some viruses are not restricted by RLRs in some contexts or encode potent RLR antagonists, and thus additional sensors may have evolved (Bowie and Unterholzner, 2008) .
Although RLRs are not strictly conserved in invertebrates such as mosquitoes and Drosophila, insects use a related helicase to combat viral infection. The DEAD-box helicase Dicer-2 (Dcr-2) is a core component of the RNAi pathway that recognizes doublestranded or structured viral RNAs and cleaves them into 21 nt small-interfering RNAs (siRNAs) (Ding and Voinnet, 2007; Sabin et al., 2013) . Virus-derived siRNAs are loaded into an Argonaute-2 (Ago2)-containing RNA-induced silencing complex that cleaves viral RNA. Additionally, during Drosophila C virus (DCV) infection, Dcr-2 controls induction of the antiviral gene Vago (Deddouche et al., 2008) .
More recently, several other DEAD-box proteins have been implicated in sensing viral nucleic acids or regulating downstream signaling. For example, DDX41 recognizes intracellular DNA and bacterial cyclic dinucleotides (Parvatiyar et al., 2012; Zhang et al., 2011b) , whereas a complex of DDX1, DDX21, and DHX36 senses viral dsRNA specifically in dendritic cells (Zhang et al., 2011a) . Other recently identified helicase sensors or components of antiviral signaling pathways include DDX3, DHX9, and DDX60 (Kim et al., 2010; Miyashita et al., 2011) . Thus, the landscape of DEAD-box helicases in innate immunity is more diverse than previously appreciated, and many antiviral helicases likely remain obscure.
As many aspects of innate immunity are conserved in flies as well as many DEAD-box helicases, we performed an RNAi screen to identify novel antiviral helicases. We focused on the arthropod-borne virus (arbovirus) Rift Valley fever virus (RVFV), a tri-segmented negative-sense RNA virus in the bunyavirus family (Ikegami and Makino, 2011) . In humans, RVFV infection typically causes an acute febrile illness but can progress to more severe manifestations such as encephalitis and hemorrhagic fever with 1%-3% mortality. In livestock, infection is particularly lethal with 100% abortion rates and near 100% fatality in neonates (Ikegami and Makino, 2011) . No effective vaccines or therapeutics exist for RVFV infection, and therefore additional targets for pharmacologic intervention are needed. Furthermore, we have shown that RVFV is not restricted by RLRs in some contexts including fibroblasts, suggesting that other sensors may restrict this pathogen (Moy et al., 2014) .
We identified Drosophila Rm62 as a novel host factor that restricts RVFV infection in vitro and in vivo. This restriction was specific for bunyaviruses, as Rm62 also controlled the replication of the distantly related bunyavirus La Crosse virus (LACV), but not viruses from the three other families tested. Remarkably, the antiviral role of Rm62 was conserved in human cells, as the human homolog DDX17 restricted RVFV infection. DDX17 was identified in a high-molecular-weight complex with Drosha and later shown to regulate the Microprocessor complex that mediates pri-miRNA processing and miRNA biogenesis, but its direct RNA targets are not fully known (Fukuda et al., 2007; Gregory et al., 2004; Mori et al., 2014; Suzuki et al., 2009) . Using CLIPseq, we found that in addition to binding cellular RNAs, DDX17 also interacts with RVFV RNA, likely via structured viral RNA elements. We found striking similarities in the mode of recognition for host and viral RNA: DDX17 binds a subset of pri-miRNA hairpins along with a well-characterized hairpin on the RVFV genome. Cloning this hairpin into Sindbis virus (SINV) decreased its replication in a DDX17-dependent manner in human and insect cells, indicating a direct antiviral function for DDX17 binding to viral RNA. Taken together, these data expand our understanding of DDX17 recognition of cellular and viral RNAs as well as the scope of DEAD-box helicases in antiviral immunity, demonstrating that the immune functions of DEAD-box genes can be evolutionarily conserved from insects to humans.
RESULTS

DEAD-Box Helicase Screen Reveals that Rm62 Restricts RVFV in Drosophila Cells
Because DEAD-box helicases are widely conserved across species (Linder and Jankowsky, 2011) , we performed a targeted RNAi screen in Drosophila cells to identify novel factors that control RVFV infection. Drosophila DL1 cells were treated with a panel of dsRNAs targeting 23 DEAD-box helicases that are conserved in humans (Table S1 available online). The cells were then infected with the MP12 strain of RVFV, stained for RVFV nucleoprotein (N) to monitor infection and analyzed using automated microscopy (Hopkins et al., 2013) .
Implementing a cut-off of a 2-fold increase in percent infection and a p < 0.05 across three independent experiments, we identified three DEAD-box helicase genes that restrict RVFV infection without impacting cell viability: me31B, CG10333, and Rm62 ( Figures 1A and 1B) . These results were independently corroborated by microscopy with depletion of Rm62, CG10333, or me31B resulting in increased infection ( Figure 1C ). The helicase me31B (DDX6) is a component of cytoplasmic granules known as processing bodies and activates mRNA decapping (Coller et al., 2001 ). Importantly, a recent genome-wide RNAi screen in Drosophila cells identified me31B as a RVFV restriction factor, validating our helicase screen (Hopkins et al., 2013) . CG10333 is the homolog of human DDX23/PRP28, a component of the U5 small ribonucleoprotein that promotes spliceosome assembly during pre-mRNA splicing (Staley and Guthrie, 1999) . Rm62, which has two human homologs (DDX5/p68 and DDX17/p72) ( Figure S1A ), has been studied in several contexts in flies and humans (Fuller-Pace, 2013) . In Drosophila, Rm62 has been shown to promote dsRNA-mediated RNAi (Ishizuka et al., 2002) , modulate chromatin insulation (Lei and Corces, 2006) , and facilitate resilencing of transcription loci after stimulation (Boeke et al., 2011; Buszczak and Spradling, 2006) . In mammals, DDX5 and DDX17 have been associated with transcriptional coactivation and miRNA processing, among other functions (Fukuda et al., 2007; Fuller-Pace, 2013; Mori et al., 2014) .
To further validate the antiviral activity of Rm62 and CG10333, we targeted these genes using independent dsRNAs, observing increased infection by immunofluorescence ( Figure S1B ), and verified efficient Rm62 silencing ( Figure S1C ). Rm62, CG10333, and me31B knockdown also increased RVFV glycoprotein Gn ( Figure 1D ) and RVFV RNA ( Figure 1E ), additional readouts of viral replication. Thus, these data identify Rm62 and CG10333 as new RVFV restriction factors.
Rm62 Is Antiviral against RVFV in Adult Flies
As Rm62 displayed the most potent antiviral effect against RVFV infection in Drosophila cells ( Figures 1D and 1E ), we next determined whether Rm62 also controls viral replication at the organismal level. To silence Rm62 in adult flies, we performed in vivo RNAi by crossing transgenic flies expressing a UAS-controlled inverted repeat transgene directed against Rm62 (UAS-Rm62 IR) to heat shock-driven Gal4 (hs-Gal4). We validated Rm62 depletion by northern blot ( Figure S2A ). Rm62-silenced flies (hs-Gal4 > UAS-Rm62 IR) and their sibling controls (+ > UASRm62 IR) were challenged with RVFV and monitored for survival. Compared to control flies, Rm62-silenced flies exhibited increased mortality after infection ( Figure 2A ). This survival defect was associated with significantly elevated viral RNA replication, suggesting that Rm62 restricts RVFV infection in vivo (Figures 2B and 2C) . Because the transgene is only expressed in adults, the increased susceptibility is not due to a developmental requirement for Rm62. Moreover, Rm62 depletion did not impact survival of uninfected flies ( Figure S2B ).
To validate our in vivo RNAi results and control for potential offtarget effects, we tested previously characterized transheterozygous Rm62 mutant flies that had substantially reduced Rm62 protein expression (Buszczak and Spradling, 2006) . RVFV-infected Rm62 mutant flies (Rm62
CB02119
/Rm62
01086
), but not uninfected flies, showed a dramatic increase in mortality compared to sibling controls (Rm62 CB02119 /+) ( Figures 2D and S2C ). Rm62 mutants also demonstrated significantly elevated RVFV RNA replication, similar to Rm62-silenced flies (Figures 2E and 2F) . Taken together, these data reveal an in vivo requirement for Rm62 in controlling RVFV infection and protecting against lethality.
Rm62 Specifically Restricts Bunyaviral Infection in Drosophila
We next evaluated the specificity of Rm62 by testing its role during infection with additional viruses. To test whether Rm62 restricts other bunyaviruses, we challenged Rm62-silenced Drosophila cells with LACV, a mosquito-transmitted bunyavirus that causes encephalitis in humans. Rm62 depletion dramatically increased the amount of recovered LACV RNA, indicating that Rm62 also controls LACV replication in vitro (Figures 3A and 3B) . Furthermore, LACV-infected Rm62 mutant flies exhibited increased mortality and LACV RNA replication, with an approximately 35-fold elevation in LACV N expression ( Figures 3C-3E ).
These data indicate that Rm62 restricts both LACV and RVFV in cells and flies.
To examine whether Rm62's antiviral activity is limited to bunyaviruses or functions more broadly, we tested additional human arboviruses from distinct classes. Vesicular stomatitis virus All data represent three independent experiments. See also Figure S1 and Table S1 .
(VSV) is a nonsegmented negative-sense RNA virus in the Rhabdovirus family, whereas SINV is a positive-sense RNA alphavirus. Notably, we observed no increase in VSV or SINV protein expression in virus-challenged Drosophila cells treated with Rm62 dsRNA (Figures S3A and S3B ). In addition, we infected Rm62 mutant flies with VSV, SINV, and DCV, a picorna-like positive-sense RNA virus that is a natural Drosophila pathogen. Rm62 mutant flies showed no increase in mortality with DCV, VSV, or SINV infection ( Figures 3F-3H ). Furthermore, we observed no increase in DCV protein, VSV RNA, or SINV RNA in Rm62 mutant flies ( Figures 3I-3K ), demonstrating that Rm62 does not restrict these viruses in vivo. Therefore, Rm62 is a selective restriction factor for bunyaviruses in flies.
Human DDX17 Controls RVFV and LACV Infection DEAD-box helicases are broadly conserved across species, with humans and mammals encoding two homologs of Rm62: DDX5 and DDX17 ( Figure S1A ). These proteins have both overlapping and unique functions, but their role in immunity is not defined. Thus, we evaluated whether DDX5 or DDX17 restrict bunyavirus infection in human cells.
To silence DDX5 and DDX17 expression, we transfected a human osteosarcoma cell line (U2OS cells) with gene-specific siRNAs or a nontargeting control siRNA ( Figure S4A ). Interestingly, whereas DDX17 silencing had no effect on DDX5 expression, DDX5 knockdown increased DDX17 protein levels, suggesting that DDX5 negatively regulates DDX17 expression, which has been observed in HeLa cells (Jalal et al., 2007) . Compared to control cells, DDX17-depleted cells showed a significant increase in percent infection and viral RNA ( Figures 4A-4D ). In contrast, we observed no difference in RVFV infection with DDX5 depletion, suggesting that DDX17 specifically limits RVFV replication in human cells. Independent siRNAs against DDX17 also augmented RVFV infection ( Figures S4B and S4C ). Furthermore, DDX17 but not DDX5 silencing increased LACV infection in U2OS cells ( Figures 4E-4G ). Taken together, these (legend continued on next page) data indicate that DDX17 restriction of bunyavirus infection is functionally conserved from flies to human cells.
Next we tested whether overexpression of DDX17 limits RVFV replication. Compared to control GFP overexpression, ectopic DDX17 expression reduced RVFV protein accumulation (Figure S4D ) and the percentage of infected cells ( Figure S4E ). These results demonstrate that DDX17 may be limiting and that increased expression can modestly attenuate RVFV infection.
Finally, we tested the specificity of human DDX17 by challenging U2OS cells with VSV. Whereas DDX17-depleted cells demonstrated increased RVFV Gn protein ( Figure 4H ), DDX17 silencing had no effect on VSV protein expression ( Figure 4I ). Therefore, as in Drosophila, DDX17 restricts the two bunyaviruses RVFV and LACV but not VSV, indicating selectivity for restricting bunyaviruses.
Some DEAD-box helicases such as RIG-I and MDA-5 control virus-induced IFN-I expression. To determine whether DDX17 similarly regulates IFN-I production, we tested whether DDX17 silencing impacts upregulation of the interferon-stimulated gene (ISG) Ifit1 (Terenzi et al., 2006) . Although VSV and RVFV infection induced Ifit1 RNA expression at 16 hr post-infection (hpi), DDX17 knockdown did not abrogate this response; in fact, Ifit1 levels were higher in DDX17-silenced cells with RVFV infection, most likely due to increased viral replication ( Figures 4J and 4K ). RVFV infection also did not induce IFNa or IFNb expression, likely because the virus encodes a potent interferon antagonist, NSs ( Figures S4F and S4G) . Notably, DDX17 depletion did not impact the expression of these genes, as well as IkBa, IRF7, and DDX58 ( Figures S4H-S4J ). Thus, our data suggest that DDX17 restricts RVFV infection in an interferon-independent manner.
Identification of DDX17-Bound RNAs by CLIP-Seq
Because DEAD-box helicases function as RNA-binding proteins, we hypothesized that DDX17 may directly bind RVFV RNAs to inhibit viral replication. To determine the specific RNAs bound to endogenous DDX17, we performed CLIP-seq, a method for purifying RNA-binding protein targets from cells under stringent conditions (Darnell, 2010) . Briefly, uninfected or RVFV-infected U2OS cells were UV-irradiated, and endogenous DDX17-bound RNAs were digested to $100 nt fragments, immunoprecipitated from cell lysates with anti-DDX17 or anti-FLAG as a control, and radiolabeled for visualization. We observed efficient depletion of DDX17 from the lysates with anti-DDX17 but not anti-FLAG (Figure 5A) . Autoradiography of RNA-protein complexes revealed extensive signal for anti-DDX17 but not anti-FLAG immunoprecipitations, suggesting enrichment for DDX17-bound RNAs (Figure 5B) . cDNA libraries were then generated from purified RNAs and submitted for Illumina deep-sequencing.
From three pooled DDX17-CLIP experiments, we obtained $80 million raw reads and $90 million raw reads from uninfected and infected cells, respectively ( Figure 5C ). We generated a composite genome index incorporating the hg19 human genome and three genomic segments of RVFV (L, M, S), with over 55% of reads aligning unambiguously to the composite genome (unique alignments). Collapsed alignments were obtained by removing PCR duplicates and retaining only one alignment for each 5 0 coordinate. Genomic intervals with at least two overlapping alignments were clustered together generating the alignment clusters. This yielded 733,542 clusters for uninfected cells and 426,135 clusters from RVFV-infected cells. Alignment clusters within human premRNA loci were further searched for significant peaks (false discovery rate [FDR] < 0.001) using an empirical algorithm (Shankarling et al., 2014) . DDX17 pre-mRNA peaks showed strong overlap between uninfected and infected cells ( Figure 5D ), indicating that the overall profile of DDX17-bound cellular RNAs is similar during infection. Next, we determined the transcript features of DDX17 pre-mRNA peaks ( Figure 5E ). Interestingly, DDX17 peaks were enriched in coding exons, 5
0 UTRs, and 3 0 UTRs, suggesting that DDX17 preferentially binds mature mRNA. Hexamer enrichment analysis of CLIP-seq peaks within protein-coding genes showed a bias for CT-and CA-repeat elements ( Figure 5F and Table S2 ). Together, these data indicate both location and sequence preference for DDX17 binding to mRNAs.
To understand the functional targets of DDX17, we used DAVID to identify KEGG GO terms enriched among protein-coding genes associated with DDX17 CLIP-seq peaks. We observed enrichment for cell adhesion as well as several cellular signaling pathways ( Figure S5A ). Intriguingly, one of the most overrepresented KEGG pathways was mitogen-activated protein kinase (MAPK) signaling ( Figure S5B ). Previous data suggest that MAPK-activated protein kinase 2 (MK2) physically interacts with DDX5 to control its localization, and that DDX5/DDX17 regulate splicing of p38 MAPK (Hong et al., 2013; Samaan et al., 2013) . Thus, DDX17-bound RNAs identified in our experiments overlap with known targets in MAPK signaling, suggesting that the CLIP-seq peaks reflect the biological activity of DDX17.
DDX17 Directly Binds to pri-miRNA Stem Loops
In addition to roles in transcriptional regulation and alternative splicing, DDX17 has been linked to miRNA biogenesis. DDX5 and DDX17 are components of the Microprocessor complex, which processes the pri-miRNA transcript into the 60-70 nt stem-loop intermediate known as the pre-miRNA (Davis et al., 2008; Gregory et al., 2004; Mori et al., 2014; Suzuki et al., 2009) . Loss of DDX17 results in decreased expression of a subset but not all miRNAs (Fukuda et al., 2007; Mori et al., 2014) . Therefore, as further validation of our CLIP-seq data, we also analyzed the intersection of DDX17 CLIP signal with annotated miRNA stem loops.
We observed 160 pri-miRNA loci that were associated with DDX17 CLIP clusters (Table S3 ). There was strong correlation in normalized CLIP signal within pri-miRNAs from uninfected and RVFV-infected samples ( Figure 6A ), suggesting that similar primiRNAs are bound by DDX17 in uninfected and infected cells. In contrast, we found no correlation between CLIP-seq signal and level of miRNA expression reported in a previous study of small RNAs in U2OS cells, indicating that DDX17 clusters represent bias for certain miRNAs independent of expression level (Figure 6B) . Among DDX17-bound miRNAs, miR-663a, miR-99b, and miR-6087 were some of the most highly represented miRNAs ( Figure 6C ). Analysis of DDX17 CLIP signal in relation to the predicted pri-miRNA stem loop showed that DDX17 clusters were preferentially localized immediately 5 0 and 3 0 to the center of the loop ( Figure 6D ). These data suggest that DDX17 interactions are strongest with the stem region of the miRNA hairpin rather than the loop. Analysis of overrepresented hexamers in DDX17-associated miRNAs did not show any enrichment of the CA-or CT-repeat elements found with the DDX17 mRNA peaks (Table  S4 ). Furthermore, de novo analysis of the bound pri-miRNAs identified no significantly enriched motifs compared to total pri-miRNA background. Thus, the interaction of DDX17 with pri-miRNAs is likely determined by RNA secondary structure.
DDX17 Binds RVFV RNAs to Restrict Viral Replication
To determine whether DDX17 regulation of miRNA biogenesis is directly involved in antiviral defense, we silenced the Micropro- See also Figure S5 and Table S2. cessor component Drosha in U2OS cells ( Figure S6A ). Loss of Drosha had no impact on RVFV replication, suggesting that the antiviral mechanism of DDX17 is independent of Drosha and the canonical miRNA pathway (Figures S6B and S6C ). Using luciferase reporter assays as previously described (Sabin et al., 2009 ), we also found that Rm62 is not required for siRNA-or miRNA-mediated silencing in Drosophila cells ( Figure S6D ). These data indicate that DDX17 does not act through RNAi to restrict RVFV infection.
Next, we tested whether DDX17 directly interacts with viral RNA by analyzing the overlap of DDX17 CLIP clusters with the RVFV genome. We observed multiple DDX17 clusters, with the highest signal on the M and S segments ( Figure 7A ). These data suggest that DDX17 binds RVFV RNA in infected U2OS cells. In addition, DDX17 viral peaks did not overlap with CAand CT-repeat motifs, suggesting that DDX17-viral interactions are not dependent on these elements ( Figure S6E) .
Because viral RNAs are often highly structured and DDX17 was enriched at the stem region of pri-miRNA hairpins, we hypothesized that DDX17 may recognize structured elements in RVFV RNAs. Indeed, we observed a prominent CLIP cluster within the intergenic region (IGR) on the S segment (between N and NSs). The IGR on other ambisense bunyaviruses has been shown to form a highly complementary sequence that folds into a hairpin to control transcription termination (Emery and Bishop, 1987) . This IGR in the RVFV antigenome similarly forms a hairpin that generates the majority of virus-derived siRNAs in infected Drosophila and mosquito cells (Sabin et al., 2013) . We defined a 75 nt RNA that overlaps the largest S segment DDX17 CLIP cluster within the IGR on the genome strand, which is predicted to form a hairpin structure that resembles miRNA stem loops ( Figure 7B ). We synthesized this RNA in vitro using T7 RNA polymerase to test whether it is bound by DDX17. Biotinylated DDX17 peak RVFV RNA efficiently precipitated DDX17 from U2OS cell lysates in a dose-dependent manner, demonstrating that DDX17 physically interacts with RVFV RNA and validating our CLIP-seq results ( Figure 7C ). In contrast, a nonspecific control from RVFV RNA not bound in our CLIP-seq data set did not precipitate DDX17 ( Figure 7D ).
To determine whether DDX17 binding on viral RNA can directly restrict viral infection, we cloned the RVFV DDX17 hairpin into the 3 0 UTR of SINV under the control of a subgenomic promoter (SINV-hp). This same strategy has been previously shown to tolerate the insertion of noncoding hairpin RNAs (Shapiro et al., 2010) . We found that control cells supported substantially less infection of SINV-hp compared to wild-type (WT) SINV (Figure 7E) . Furthermore, whereas depletion of DDX17 led to modest increases in SINV capsid production of WT virus, loss of DDX17 led to large increases in capsid production from SINV-hp virus ( Figure 7E) . In addition, we tested whether this RVFV Tables S3 and S4. hairpin also impacted SINV replication in Drosophila cells. WT SINV was unaffected by the loss of Rm62 ( Figure 7F ). Moreover, as we found in human cells, control RNAi-treated cells supported less infection of SINV-hp than WT SINV, and depletion of Rm62 led to a large increase in SINV capsid production from SINV-hp virus ( Figure 7F ). A second DDX17 peak at the 5 0 end of the S genomic segment was also predicted to form a hairpin (Figure S6F) , and cloning this hairpin into SINV (SINV-5 0 hp) also sensitized the virus to DDX17 restriction in Drosophila and human cells (Figures S6G and S6H) . Together, these data demonstrate that the presence of a DDX17-binding site on viral RNA is restrictive and that this repression can be alleviated by loss of DDX17 across hosts.
We next assessed the localization of DDX17 and DDX5 during infection by immunofluorescence, as RVFV and SINV RNA replication occur exclusively in the cytoplasm. We validated the specificity of these antibodies for immunofluorescence using RNAi ( Figures S6I and S6J) . As previously reported, DDX17 was found in the nucleus in uninfected cells ( Figure 7G ) (Bortz et al., 2011) . At 12 hpi, however, we observed some DDX17 staining in cytosolic puncta that colocalized with RVFV nucleocapsid protein N, which coats viral RNA and facilitates replication ( Figure 7G ). In contrast, DDX5 remained in the nucleus in the presence and absence of infection ( Figure 7H ), suggesting a distinct localization pattern for DDX17. Collectively, these data suggest that DDX17 may gain access to cytosolic RVFV replication complexes during infection and bind viral RNA to antagonize viral replication.
DISCUSSION
Emerging data have begun to uncover specialized functions for mammalian DEAD-box helicases in immunity, particularly in See also Figure S6 .
the sensing of viral nucleic acids to activate interferon induction (Fullam and Schrö der, 2013) . However, whether DEAD-box helicases play interferon-independent roles in antiviral immunity remains unclear. Moreover, whether antiviral DEAD-box helicases exist primarily in mammals or evolved immune functions in lower organisms has not been fully explored. We have discovered a specific and evolutionarily conserved role for the helicase DDX17 in restricting infection with RVFV, a major human arbovirus that lacks effective therapeutics. Through an RNAi screen in Drosophila cells, we identified Rm62 as an anti-RVFV helicase gene. Rm62 is also essential for resistance to RVFV infection in vivo, as RVFV-challenged Rm62-deficient flies showed increased viral replication and mortality. Loss of Rm62 increased LACV infection but not SINV, VSV, or DCV infection, and silencing closely related DEAD-box helicase genes had no effect on RVFV. Thus, Rm62 is as an essential and specific virus restriction factor in flies.
Mammals encode two orthologs of Rm62, DDX5 and DDX17, which have been widely studied in transcriptional coactivation, mRNA splicing, and miRNA processing. In addition, previous studies have implicated DDX5 and DDX17 in promoting the replication of several viruses, such as hepatitis C virus and influenza virus (Bortz et al., 2011; Goh et al., 2004) . We found that silencing DDX17 but not DDX5 increased RVFV replication in human U2OS cells, whereas DDX17 overexpression inhibited RVFV infection. Although we cannot unequivocally rule out any antiviral function for DDX5, as DDX5 depletion upregulated DDX17 expression and we could not efficiently knock down both proteins simultaneously in U2OS cells, basal DDX5 levels were not able to compensate for DDX17 loss. Therefore, the antiviral activity of DDX17 is evolutionarily conserved from invertebrates to mammals, suggesting an ancient origin for DEAD-box helicases in innate immunity.
DDX17 joins a growing list of antimicrobial DEAD-box proteins that function as cytoplasmic sensors for viral nucleic acids. For example, DDX41 binds DNA to control IFN-I and proinflammatory cytokine induction (Zhang et al., 2011b) . Additionally, DDX3 interacts with IKKε and TBK-1 to regulate IFN-I activation downstream of virus recognition (Soulat et al., 2008) . In contrast, DDX17 is dispensable for antiviral gene expression, suggesting that DDX17 acts independently of IFN-I, which is distinct from previously defined antiviral DEAD-box genes.
Previous reports have proposed that Rm62 and DDX17 regulate RNAi, which is a well-characterized antiviral pathway in invertebrates. In Drosophila cells, Rm62 has been shown to bind Ago2 and control siRNA-mediated silencing (Ishizuka et al., 2002) . Based on these findings, one study suggested that Rm62-deficient flies infected with Drosophila X virus (DXV) have increased mortality due to defective antiviral RNAi (Zambon et al., 2006) ; however, this study did not use sibling-matched or uninfected controls and did not monitor viral replication. In mammalian cells, DDX5 and DDX17 are found in the Microprocessor complex and regulate miRNA biogenesis. However, our data suggest that Rm62 and DDX17 restrict viral infection in an RNAi-independent manner. First, we found that Rm62 controls the replication of RVFV but not VSV, SINV, or DCV, viruses that are restricted by antiviral RNAi in flies (Galiana-Arnoux et al., 2006; Mueller et al., 2010; Sabin et al., 2009; van Rij et al., 2006) . Second, Rm62 has not been found to control siRNA-or miRNA-mediated RNA silencing in more recent in vitro and in vivo screens, which we confirmed in our experiments (Cziko et al., 2009; Zhou et al., 2008) . Third, RNAi is not generally thought to restrict viral infection in mammalian somatic cells, whereas its antiviral function in embryonic and undifferentiated mammalian cell types may be active (Cullen et al., 2013; Li et al., 2013; Maillard et al., 2013) . Lastly, depletion of the Microprocessor component Drosha, which can act as an interferon-independent antiviral factor (Shapiro et al., 2014) , did not impact RVFV infection. Although there may be additional complexity and interplay between DDX17, miRNA biology, and antiviral defense, our data suggest that DDX17's antiviral function is independent of its role in miRNA biogenesis.
CLIP-seq studies revealed that DDX17 physically associates with viral RNA to control viral infection. One of the DDX17-binding peaks, corresponding to the IGR between the N and NSs genes on the genomic S segment, efficiently precipitated DDX17 from cell lysates. Interestingly, this region forms an extensive hairpin (Sabin et al., 2013) , suggesting that DDX17 may recognize highly structured stem loops on viral RNAs. Furthermore, in infected cells, DDX17 forms cytoplasmic puncta overlapping with RVFV N. This relocalization to viral replication complexes may allow DDX17 to access and bind structured viral RNA elements and thereby limit replication.
Indeed, by expressing the RVFV hairpin from SINV (SINV-hp), we demonstrated that SINV becomes hypersensitive to DDX17 in both human and insect cells. This suggests that binding of DDX17 to viral RNA is sufficient to mediate its antiviral effect. How this binding limits viral replication remains to be clarified in future studies. DDX17 may associate with additional protein cofactors that mediate its antiviral function. For instance, DDX17 has been shown to bind Dcp2 and Dcp1a, which remove the 5 0 cap from mRNAs, and the exonuclease Xrn1, which mediates 5 0 -to-3 0 RNA degradation (Zhu et al., 2011) . Interestingly, a recent study showed that Drosophila Dcp2 restricts RVFV infection, although this may be in an indirect manner by limiting the pool of cellular mRNA substrates that RVFV utilizes for its own replication (Hopkins et al., 2013) . DDX5 and DDX17 also bind components of the RNA exosome, a complex that catalyzes 3 0 -to-5 0 RNA degradation (Chen et al., 2008; Zonta et al., 2013) . Consequently, DDX17 may act as the sensor that brings viral RNA targets to the RNA degradation machinery, or it may unwind viral RNAs to facilitate degradation. The decapping machinery, exosome, and DDX17 have additionally been linked to the antiviral protein ZAP (Zhu et al., 2011) . ZAP is known to restrict SINV replication in human cells (Bick et al., 2003) , and we found a modest effect of DDX17 depletion on WT SINV, albeit this effect was not as strong as with SINVhp. In contrast, flies do not encode a ZAP homolog, and Rm62 silencing had no impact on WT SINV replication in insect cells. As maximal DDX17 restriction of SINV depended on the RVFV stem loop in both cells types, DDX17's antiviral function in RVFV infection is likely independent of ZAP and dependent on direct viral RNA binding.
Why DDX17 specifically targets bunyaviral RNAs is also uncertain, as the rules that direct RNA-binding activity of DDX17, as well as DEAD-box proteins in general, are difficult to decipher. We suspect that antiviral specificity derives from a combination of cellular localization and specific RNA structures. Our data suggest that SINV and VSV do not have the appropriate targeting signals. In addition, the correlation between DDX17 expression pattern and viral pathogenesis must be characterized. DDX17 is ubiquitously expressed and is not transcriptionally induced by IFN-I, and our data suggest that subcellular localization but not expression level is responsive to infection. Further studies will allow us to better define the regulation of DDX17 and explore the relationship between tissue type and antiviral activity.
Beyond elucidating new DDX17 functions in immunity, our data reveal important insights into the mechanism of DDX17 recognition for diverse RNAs. Our data suggest that DEAD-box proteins are highly amenable to CLIP-seq analysis. We found that DDX17 cellular mRNA targets are enriched for CT-and CA-repeat elements, suggesting that primary sequence contributes to mRNA recognition. In contrast, DDX17-bound pri-miRNAs were not enriched for this element or any other linear sequence (p > 0.05); instead, DDX17 was localized to the miRNA stem, suggesting that it recognizes pri-miRNAs via secondary structure. We compared our bound pri-miRNAs with two studies that monitored miRNAs upon loss of DDX17 (Fukuda et al., 2007; Mori et al., 2014) . Fukuda et al. identified 94 miRNAs that were decreased upon loss of p72 in mouse embryonic fibroblasts that derive from 82 pre-miRNAs expressed in U2OS cells, of which 32% were directly bound by DDX17 in our studies. In another study, Mori et al. identified 317 miRNAs misregulated by DDX17 depletion in HaCaT cells; of the 160 DDX17-bound miRNAs from our study, 60 were analyzed in their cells, and 30 were found to be regulated by DDX17 (50%). Furthermore, Mori et al. identified a sequence motif in the 3 0 flanking segment of a subset of pri-miRNAs that were impacted by DDX17 levels ([GTA]CATC [CTA] ) and focused on miR-21, a miRNA that we also identified as bound by DDX17. Mori et al. demonstrated by in vitro binding assays that both the motif as well as a complete stem loop were required for full binding activity. Altogether, these data suggest that DDX17 recognizes the pri-miRNA stem in the context of a 3 0 tail. This would bias DDX17 binding to primiRNAs over pre-miRNAs because some additional binding energy would be derived from the flanking regions and would facilitate DDX17 binding to stem loops within larger RNAs as is found in viral RNAs. In further support of this, the ([GTA]CATC [CTA]) sequence motif was over-represented in our mRNA peaks (p = 3.7 3 10 À17 ), suggesting that this sequence is indeed a preferred binding site for DDX17 in diverse RNAs.
In conclusion, our data reveal striking parallels between DDX17 recognition of pri-miRNAs and viral RNAs: in both cases, DDX17 targets a structured stem loop, either to facilitate miRNA processing or to mediate virus inhibition.
EXPERIMENTAL PROCEDURES
RNAi in Drosophila Cells dsRNAs were synthesized as described (Boutros et al., 2004) . Drosophila cells were passaged into serum-free media and seeded onto 384-well or 6-well plates containing 250 ng or 4 mg of dsRNA/well, respectively. Complete media was added 1 hr later, and the cells were incubated for 3 days for knockdown.
CLIP-Seq U2OS cells were seeded onto 10 cm plates and infected with RVFV (multiplicity of infection [moi] = 3) for 16 hr. The cells were washed in ice-cold HBSS (GIBCO) and irradiated at 254 nm (400 mJ/cm 2 ) in a Stratalinker 1800 (Stratagene). The cells were pelleted, flash frozen in liquid nitrogen, and stored at À80
C. Anti-DDX17 or anti-FLAG was bound to Dynabeads (Invitrogen) in binding buffer (0.1 M Na-phosphate, pH 8, and 0.1% NP-40). Cell pellets were lysed in 13 PXL (13 PBS (no Mg 2+ and no Ca 2+ , 0.1% SDS, 0.5% deoxycholate and 0.5% NP-40) with protease inhibitors and RNasin, and lysates were treated with RNase T1 (1:1000 dilution) and RQ1 DNase for 10 min at 37 C. Lysates were incubated with beads overnight at 4 C. RNA linkers (RL3 and RL5) and DNA primers (DP3 and DP5, DSFP3 and DSFP5) were prepared and used as described (Vourekas et al., 2012) . Samples were resolved by NuPAGE and transferred to nitrocellulose membrane, which was exposed to film, and bands were excised above the expected molecular weight (MW) of DDX17. RNA extraction, 5 0 -linker ligation, RT-PCR, and reamplification were performed as described (Vourekas et al., 2012) . cDNA libraries were purified and submitted for Illumina deep sequencing.
CLIP-Seq Data Analysis
Raw CLIP-seq reads were trimmed from the 3 0 end to remove 2+ contiguous basecalls with Phred quality scores of 0. Sequencing adaptors were removed from the 3 0 end with cutadapt version 0.9.4, and homopolymeric runs of 6+ basecalls of the same nucleotide were removed. Trimmed reads were aligned to a composite genome index containing hg19 and RVFV strain MP-12 genomes, allowing at most two mismatches and retaining only unambiguous alignments. PCR duplicates were removed by retaining only one alignment for each 5 0 coordinate generating collapsed alignments. Genomic intervals with at least two overlapping alignments were clustered together generating the alignment clusters. Alignment clusters within annotated protein-coding genes (refSeq NM_*) and ncRNA genes (refSeq NR_*) were further searched for significant peaks with an empirical algorithm, using 100 iterations of permutations and a FDR threshold of 0.001 (Xue et al., 2009 ). DDX17-pre-miRNA interactions were identified by intersection of alignment clusters with pre-miRNA loci extracted from miRBase release 20. Mature miRNAs were associated with pre-miRNAs and 160 pre-miRNAs had at least one CLIP cluster in either uninfected or infected cells. For those pre-miRNAs, we included the total number of collapsed alignments for subsequent analysis. To analyze miRNA expression levels in U2OS cells, we aligned small RNA-seq reads from all three replicates of control-transfected U2OS cells (GEO submission GSM889286) (Wei et al., 2012) using the same alignment settings as above and computed mean RPKM values for each pre-miRNA hairpin from miRBase. To identify the relative location of DDX17 binding on pre-miRNA loci, center coordinates for each pre-miRNA locus from miRBase were computed, then intervals from À250 nt to +250 nt around the center were generated. Intervals that do not intersect any CLIP cluster were discarded. For each locus, the clusters were compressed such that each nucleotide was bound or unbound (0 or 1). These were summed across the loci and divided by the total to present the fraction bound at each position.
Computation was executed on the Penn Genome Frontiers Institute High Performance Compute cluster, using Perl version 5.16.2, Python version 2.7.3, R version 3.0.2, bedtools version 2.16.2, and samtools version 0.1.18.
Motif Enrichment Analysis
Each hexamer occurring within DDX17-pre-mRNA interaction sites was assigned a Z score by comparing observed hexamer frequencies to the backgrounds computed by permutation of the coordinates of interaction sites 100 times within the pre-mRNA in which that site occurred. Multiple sequence alignments of the top 20 hexamers were generated with ClustalW2, and sequence logos were generated with WebLogo version 2.8.
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